<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37382269</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2-STAT3 signaling pathway.</ArticleTitle><Pagination><StartPage>e903</StartPage><MedlinePgn>e903</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e903</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.903</ELocationID><Abstract><AbstractText Label="BACKGROUND">The aryl hydrocarbon receptor (AhR) is a critical regulator of the pathogenesis of autoimmune disorders. We aimed to investigate the therapeutic effect of the AhR agonist tapinarof during the development of systemic lupus erythematosus (SLE).</AbstractText><AbstractText Label="METHODS">MRL/lpr mice were intraperitoneally injected with 1 or 5&#x2009;mg/kg tapinarof for 6 weeks. Kidney histopathology was evaluated using hematoxylin and eosin (H&amp;E) and Periodic-Acid-Schiff (PAS) staining. Immunofluorescence microscopy was performed to detect immune complex renal depositions. Flow cytometry (FCM) analysis was carried out to determine the proportions of T and B cell subsets. Realtime qPCR was used to quantify the expression of Tfh cell-associated genes. We conducted an in vitro polarization experiment to observe the effect of tapinarof on Tfh differentiation. Western blotting was used to detect the expression of target proteins.</AbstractText><AbstractText Label="RESULTS">We found that tapinarof treatment ameliorated lupus phenotypes, including splenomegaly, lymph node enlargement, kidney damages, immune complex deposition, and excessive secretion of antibodies. Additionally, we showed that Treg subpopulation frequencies significantly increased in MRL/lpr mice treated with tapinarof, while the proportion of Th1/Th2 cells was reduced after tapinarof administration. Moreover, tapinarof suppressed Tfh cell differentiation and germinal center (GC) reaction in vivo. The inhibitory effect of tapinarof on Tfh cells was further verified in the in vitro Tfh cell polarization experiment. Realtime qPCR revealed that tapinarof repressed the expression of Tfh signature genes. Mechanistically, tapinarof significantly inhibited the phosphorylation levels of JAK2 and STAT3. The capacity for Tfh differentiation was partially rescued by the STAT3 activator Colivelin TFA. Furthermore, our in vitro Tfh polarization experiments indicated that tapinarof suppressed Tfh cell development in SLE.</AbstractText><AbstractText Label="CONCLUSIONS">Our data demonstrated that tapinarof modulated the JAK2-STAT3 pathway to suppress Tfh cell differentiation for the treatment of lupus symptoms in MRL/lpr mice.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Qilu Children's Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peiyi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Jinan Central Hospital, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Animal Laboratory Center, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Animal Laboratory Center, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kailin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Central Laboratory, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Central Laboratory, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central Laboratory, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Central Laboratory, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xin</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0001-9420-3113</Identifier><AffiliationInfo><Affiliation>Central Laboratory, Institute of Medical Science, The Second Hospital of Shandong University, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000936">Antigen-Antibody Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018336">Receptors, Aryl Hydrocarbon</NameOfSubstance></Chemical><Chemical><RegistryNumber>84HW7D0V04</RegistryNumber><NameOfSubstance UI="C571829">tapinarof</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="C507926">Jak2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494087">Stat3 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000936" MajorTopicYN="N">Antigen-Antibody Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018336" MajorTopicYN="N">Receptors, Aryl Hydrocarbon</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000084522" MajorTopicYN="Y">T Follicular Helper Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AhR</Keyword><Keyword MajorTopicYN="N">SLE</Keyword><Keyword MajorTopicYN="N">T follicular helper cell</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>7</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37382269</ArticleId><ArticleId IdType="pmc">PMC10266146</ArticleId><ArticleId IdType="doi">10.1002/iid3.903</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nature Immunol. 2001;2(9):764&#x2010;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11526379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Yang X, Zou H, Chu Y, Li M. Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus. Rheumatology. 2011;50(8):1366&#x2010;1372.</Citation><ArticleIdList><ArticleId IdType="pubmed">21489974</ArticleId></ArticleIdList></Reference><Reference><Citation>Spolski R, Leonard WJ. IL&#x2010;21 and T follicular helper cells. Int Immunol. 2010;22(1):7&#x2010;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2795365</ArticleId><ArticleId IdType="pubmed">19933709</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco P, Ueno H, Schmitt N. T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis: HIGHLIGHTS. Eur J Immunol. 2016;46(2):281&#x2010;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">26614103</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L, He Y, Cao Y, et al. Functional differentiation and regulation of follicular T helper cells in inflammation and autoimmunity. Immunology. 2021;163(1):19&#x2010;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8044332</ArticleId><ArticleId IdType="pubmed">33128768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol. 1995;35:307&#x2010;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">7598497</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimba S, Watabe Y. Crosstalk between the AHR signaling pathway and circadian rhythm. Biochem Pharmacol. 2009;77(4):560&#x2010;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">18983986</ArticleId></ArticleIdList></Reference><Reference><Citation>Safe S, Wang F, Porter W, Duan R, McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol Lett. 1998;102&#x2010;103:343&#x2010;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">10022276</ArticleId></ArticleIdList></Reference><Reference><Citation>Perepechaeva ML, Grishanova AY. The role of aryl hydrocarbon receptor (AhR) in brain tumors. Int J Mol Sci. 2020;21(8):2863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7215596</ArticleId><ArticleId IdType="pubmed">32325928</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri T. Aryl hydrocarbon receptor connects inflammation to breast cancer. Int J Mol Sci. 2020;21(15):5264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7432832</ArticleId><ArticleId IdType="pubmed">32722276</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaronen M, Quintana FJ. Immunological relevance of the coevolution of IDO1 and AHR. Front Immunol. 2014;5:521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4202789</ArticleId><ArticleId IdType="pubmed">25368620</ArticleId></ArticleIdList></Reference><Reference><Citation>Trikha P, Lee DA. The role of AhR in transcriptional regulation of immune cell development and function. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188335.</Citation><ArticleIdList><ArticleId IdType="pubmed">31816350</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez FJ, Fernandez&#x2010;Salguero P. The aryl hydrocarbon receptor: studies using the AHR&#x2010;null mice. Drug Metab Dispos. 1998;26(12):1194&#x2010;1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">9860927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrlich AK, Pennington JM, Bisson WH, Kolluri SK, Kerkvliet NI. TCDD, FICZ, and other high affinity AhR ligands dose&#x2010;dependently determine the fate of CD4+ T cell differentiation. Toxicol Sci. 2018;161(2):310&#x2010;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837604</ArticleId><ArticleId IdType="pubmed">29040756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Ma J, Takeuchi M, et al. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Investig Ophthalmol Vis Sci. 2010;51(4):2109&#x2010;2117.</Citation><ArticleIdList><ArticleId IdType="pubmed">20007828</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson JM, Shepherd DM. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicol Sci. 2011;120(1):68&#x2010;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044199</ArticleId><ArticleId IdType="pubmed">21131560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kummari E, Rushing E, Nicaise A, McDonald A, Kaplan BLF. TCDD attenuates EAE through induction of FasL on B cells and inhibition of IgG production. Toxicology. 2021;448:152646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785643</ArticleId><ArticleId IdType="pubmed">33253778</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Hanieh H, Nakahama T, Kishimoto T. The roles of aryl hydrocarbon receptor in immune responses. Int Immunol. 2013;25(6):335&#x2010;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">23580432</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Jiang L, Liu R, et al. Association between the ratio of aryl hydrocarbon receptor (AhR) in Th17 cells to AhR in Treg cells and SLE skin lesions. Int Immunopharmacol. 2019;69:257&#x2010;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">30743201</ArticleId></ArticleIdList></Reference><Reference><Citation>Collison J. AhR in SLE. Nat Rev Nephrol. 2018;14(8):476.</Citation><ArticleIdList><ArticleId IdType="pubmed">29802401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine H, Watanabe H, Gilkeson GS. Enrichment of anti&#x2010;glomerular antigen antibody&#x2010;producing cells in the kidneys of MRL/MpJ&#x2010;Fas(lpr) mice. J Immunol. 2004;172(6):3913&#x2010;3921.</Citation><ArticleIdList><ArticleId IdType="pubmed">15004199</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453(7191):65&#x2010;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">18362915</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur AN, Chang HC, Zisoulis DG, et al. Stat3 and Stat4 direct development of IL&#x2010;17&#x2010;secreting Th cells. J Immunol. 2007;178(8):4901&#x2010;4907.</Citation><ArticleIdList><ArticleId IdType="pubmed">17404271</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser CL, Lawrence BP. The aryl hydrocarbon receptor modulates T follicular helper cell responses to influenza virus infection in mice. J Immunol. 2022;208(10):2319&#x2010;2330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9117429</ArticleId><ArticleId IdType="pubmed">35444027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wing JB, Tekg&#xfc;&#xe7; M, Sakaguchi S. Control of germinal center responses by T&#x2010;follicular regulatory cells. Front Immunol. 2018;9:1910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6117393</ArticleId><ArticleId IdType="pubmed">30197643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi R, Kumar D, Burns EJ, et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell&#x2010;like and Foxp3(+) regulatory T cells. Nature Immunol. 2010;11(9):846&#x2010;853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929008</ArticleId><ArticleId IdType="pubmed">20676092</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana FJ, Murugaiyan G, Farez MF, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci. 2010;107(48):20768&#x2010;20773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996442</ArticleId><ArticleId IdType="pubmed">21068375</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissonnette R, Chen G, Bolduc C, et al. Efficacy and safety of topical WBI&#x2010;1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo&#x2010;controlled clinical trial. Arch Dermatol. 2010;146(4):446&#x2010;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">20404242</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissonnette R, Bolduc C, Maari C, et al. Efficacy and safety of topical WBI&#x2010;1001 in patients with mild to moderate psoriasis: results from a randomized double&#x2010;blind placebo&#x2010;controlled, phase II trial. J Eur Acad Dermatol Venereol. 2012;26(12):1516&#x2010;1521.</Citation><ArticleIdList><ArticleId IdType="pubmed">22077962</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SH, Jayawickreme C, Rickard DJ, et al. Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans. J Invest Dermatol. 2017;137(10):2110&#x2010;2119.</Citation><ArticleIdList><ArticleId IdType="pubmed">28595996</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte JH, Di Meglio P, Hirota K, Ahlfors H, Stockinger B. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLoS One. 2013;8(11):e79819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3828240</ArticleId><ArticleId IdType="pubmed">24244565</ArticleId></ArticleIdList></Reference><Reference><Citation>Goropev&#x161;ek A, Holcar M, Av&#x10d;in T. The role of STAT signaling pathways in the pathogenesis of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2017;52(2):164&#x2010;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">27216430</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray JP, Marshall HD, Laidlaw BJ, Staron MM, Kaech SM, Craft J. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity. 2014;40(3):367&#x2010;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992517</ArticleId><ArticleId IdType="pubmed">24631156</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang WZ, Li H, Jiang B, et al. Therapeutic effects of artesunate on lupus&#x2010;prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2&#x2010;STAT3 signaling pathway. Phytomedicine. 2019;62:152965.</Citation><ArticleIdList><ArticleId IdType="pubmed">31129432</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>